(Q39138372)

9 September 2017

title

Knockdown of lipocalin-2 suppresses the growth and invasion of prostate cancer cells (English)

1 reference

9 September 2017

1 reference

Min-Che Tung

1

1 reference

9 September 2017

Shu-Ching Hsieh

2

1 reference

9 September 2017

Shun-Fa Yang

3

1 reference

9 September 2017

Chun-Wen Cheng

4

1 reference

9 September 2017

Rong-Tzong Tsai

5

1 reference

9 September 2017

Shao-Chuan Wang

6

1 reference

9 September 2017

Min-Hsien Huang

7

1 reference

9 September 2017

Yi-Hsien Hsieh

8

1 reference

9 September 2017

publication date

15 June 2013

1 reference

9 September 2017

1 reference

9 September 2017

volume

73

1 reference

9 September 2017

issue

12

1 reference

9 September 2017

page(s)

1281-1290

1 reference

Cumulative prevalence of prostatism matches the autopsy prevalence of benign prostatic hyperplasia

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22670

Recent advances on multiple tumorigenic cascades involved in prostatic cancer progression and targeting therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22670

A 25 kDa α2‐microglobulin‐related protein is a component of the 125 kDa form of human gelatinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22670

Tissue involution and the acute phase response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22670

Relationships of lipocalin 2 with breast tumorigenesis and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22670

NGAL expression is elevated in both colorectal adenoma-carcinoma sequence and cancer progression and enhances tumorigenesis in xenograft mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22670

Lipocalin2 expressions correlate significantly with tumor differentiation in epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22670

Upregulation of neutrophil gelatinase-associated lipocalin in oesophageal squamous cell carcinoma: significant correlation with cell differentiation and tumour invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22670

Neutrophil gelatinase-associated lipocalin: a novel suppressor of invasion and angiogenesis in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22670

Inhibition of lipocalin 2 impairs breast tumorigenesis and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22670

Lipocalin 2 is required for BCR-ABL-induced tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22670

The neutrophil gelatinase-associated lipocalin (NGAL), a NF-kappaB-regulated gene, is a survival factor for thyroid neoplastic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22670

NGAL decreases E-cadherin-mediated cell-cell adhesion and increases cell motility and invasion through Rac1 in colon carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22670

Lipocalin2 promotes invasion, tumorigenicity and gemcitabine resistance in pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22670

Lipocalin-2 induces apoptosis in human hepatocellular carcinoma cells through activation of mitochondria pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22670

ER stress drives Lipocalin 2 upregulation in prostate cancer cells in an NF-κB-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22670

GLI1 confers profound phenotypic changes upon LNCaP prostate cancer cells that include the acquisition of a hormone independent state

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22670

Overexpression of Akt/PKB modulates N-myristoyltransferase activity in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22670

Disruption of the Lcn2 gene in mice suppresses primary mammary tumor formation but does not decrease lung metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22670

Overexpression of myeloid zinc finger 1 suppresses matrix metalloproteinase-2 expression and reduces invasiveness of SiHa human cervical cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22670

Phenotypic and genotypic characterization of commonly used human prostatic cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22670

Matrix metalloproteinases and tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22670

Lipocalin 2 expression is associated with aggressive features of endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22670

CDK inhibitors: positive and negative regulators of G1-phase progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22670

Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22670

The role of lipocalin 2 and its concernment with human nonmetastatic clone 23 type 1 and p53 in carcinogenesis of uterine cervix.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22670

BRG1 expression is increased in human glioma and controls glioma cell proliferation, migration and invasion in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22670

Interstitial guidance of cancer invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22670

RECK overexpression decreases invasive potential in prostate cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22670

Membrane-type-1 matrix metalloproteinase, matrix metalloproteinase 2, and tissue inhibitor of matrix proteinase 2 in prostate cancer: identification of patients with poor prognosis by immunohistochemistry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22670

Ectopic expression of neutrophil gelatinase-associated lipocalin suppresses the invasion and liver metastasis of colon cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22670

Lipocalin 2 diminishes invasiveness and metastasis of Ras-transformed cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22670

The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22670

A gene transcription signature associated with hormone independence in a subset of both breast and prostate cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22670

21 January 2018

Identifiers

DOI

10.1002/PROS.22670

1 reference

9 September 2017

1 reference